BLS Pharmaceuticals Limited (ASX:BLS)
Australia · Delayed Price · Currency is AUD 1.180
-0.025 (-2.07%)
Sep 22, 2026, 4:10 PM AEST
BLS Pharmaceuticals Market Cap
BLS Pharmaceuticals has a market cap or net worth of 277.52 million as of September 21, 2026. Its market cap has increased by 211.66% in one year.
Market Cap
277.52M
Enterprise Value
272.66M
Revenue
73.91M
Ranking
n/a
PE Ratio
17.99
Stock Price
1.18
ChartMarket Cap Chart
Since April 10, 2012, BLS Pharmaceuticals's market cap has increased from 31.38M to 277.52M, an increase of 784.38%. That is a compound annual growth rate of 16.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 277.52M | 196.91% |
| Dec 31, 2025 | 93.47M | 68.93% |
| Dec 31, 2024 | 55.33M | 164.50% |
| Dec 29, 2023 | 20.92M | 30.94% |
| Dec 29, 2022 | 15.98M | -13.94% |
| Dec 31, 2021 | 18.56M | 141.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 416.03M |
| Racura Oncology | 409.78M |
| Starpharma Holdings | 381.48M |
| Tetratherix | 328.96M |
| Actinogen Medical | 223.18M |
| Orthocell | 200.16M |
| Nyrada | 153.20M |
| Paradigm Biopharmaceuticals | 146.80M |